<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: CD164 (Endolyn) is a sialomucin, which has been found to play roles in regulating proliferation, <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, and differentiation of hematopoietic stem cells </plain></SENT>
<SENT sid="1" pm="."><plain>Possible association of CD164 with solid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development remains unknown </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: We first studied CD164 expression in biopsies from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, breast, and <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovary cancer</z:e> patients by semi-quantitative immunohistochemistry, and found that CD164 was strongly expressed in <z:hpo ids='HP_0000001'>all</z:hpo> the <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> samples compared to the matching <z:mpath ids='MPATH_458'>normal</z:mpath> colon tissues </plain></SENT>
<SENT sid="3" pm="."><plain>The possible roles of CD164 in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> development were further investigated using a well-established human <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell line HCT116 </plain></SENT>
<SENT sid="4" pm="."><plain>We found that knockdown of CD164 expression in HCT116 cells significantly inhibited cell proliferation, mobility, and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in vitro and in vivo </plain></SENT>
<SENT sid="5" pm="."><plain>The knockdown of CD164 expression was associated with decreased chemokine receptor CXCR4 expression HCT116 cell surface and immunoprecipitation studies showed that CD164 formed complexes with CXCR4 </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: CD164 is highly expressed in the <z:hpo ids='HP_0003003'>colon cancer</z:hpo> sites, and it promotes HCT116 <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell proliferation and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> both in vitro and in vivo, and the effects may act through regulating CXCR4 signaling pathway </plain></SENT>
<SENT sid="7" pm="."><plain>Therefore, CD164 may be a new target for diagnosis and treatment for <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
</text></document>